Back

Timing of bleeding and ischemic events after PCI in high and very high bleeding risk patients treated with 1-month DAPT: a patient-level pooled analysis of clinical trials

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Outcomes in left main percutaneous coronary intervention Outcome ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Davide Cao

Humanitas University, Milan (Italy)

8 More presentations in this session

Presentation thumbnail
Cardiovascular events following directional coronary atherectomy: a comparison of drug-coated balloon vs. newer-generation drug-eluting stent in left main coronary artery bifurcation lesions
Doctor K. Murai (Osaka, JP)
Abstract Slides Video
Presentation thumbnail
Ostial stent coverage in LMCA PCI: impact on long-term outcomes
Assistant Professor Y. Takei (Yokohama, JP)
Abstract Slides Video
Presentation thumbnail
Stent expansion in novel platinum-chromium versus conventional cobalt-chromium everolimus-eluting stents for left main coronary artery disease: the MAGARS-LM study
Doctor T. Warisawa (Tokyo, JP)
Abstract Slides Video
Presentation thumbnail
Five-year outcome after unprotected distal left main percutaneous coronary interventions according to complexity defined by DEFINITION criteria
Doctor O. Nemeth (Budapest, HU)
Abstract Slides Video
Presentation thumbnail
Clinical outcomes of management options for significant unprotected left main coronary artery disease
Assistant Professor G. Tan (Shatin, HK)
Abstract Slides Video

Access the full session

Session thumbnail
Outcomes in left main percutaneous coronary intervention

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Abbreviated versus standard dual antiplatelet therapy time after PCI in high bleeding risk patients with acute coronary syndrome - a report from the SWEDEHEART registry
thumbnail
Congress Presentation
Pattern of dual antiplatelet use and 12-month outcomes stratified by bleeding and ischemic risk in acute coronary syndrome patients undergoing percutaneous coronary intervention
thumbnail
Congress Presentation
Dual antiplatelet therapy de-escalation followed by aspirin or P2Y12 inhibitor monotherapy after PCI for acute coronary syndrome: a systematic review and meta-analysis

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources